Loading Events

« All Events

World Vaccine Congress Europe 2022

2022-10-11から2022-10-14

【ワクチン業界を代表するカンファレンス】

World Vaccine Congressは、ワクチンに特化した北米最大規模のカンファレンスです。基礎研究から商業生産まで、ワクチンのバリューチェーン全体を網羅しています。製薬会社、医療機関からワクチンの流通に関わるすべてのステークホルダーに最新動向を提供しています。World Vaccine Congressはヨーロッパと北米で開催されています。

主催者サイトへ

基本情報:

国/地域
スペイン
都市名
バルセロナ
イベントタイプ
カンファレンス

◆主要な登壇者:(最新のリストはこちらへ ⇒ スピーカーリスト

注目の登壇者2021年

  • Annaliesa Anderson, Chief Scientific Officer, Bacterial Vaccines & The Hospital Business Unit, ファイザー/Pfizer 
  • Prakash Bhuyan, MD, Vice President, Head of Infectious Diseases, Clinical Development, アストラゼネカ/Astrazeneca
  • Thomas Breuer, Senior Vice President, Chief Medical Officer, グラクソ・スミスクライン/GSK Vaccines
  • Dr Miles Carroll, Head of Research & Development Institute, Public Health England
  • Elisabeth Erlacher Vindel, Head of the Antimicrobial Resistance & Veterinary Products Department, World Organisation for Animal Health
  • Anthony Fiore, Chief, Epidemiology Research & Innovations Branch, Division of Healthcare Quality Promotion, NCEZID, アメリカ疾病予防管理センター/CDC
  • Adrian Hill, Director & Professor, ジェンナー研究所/The Jenner Institute – University of Oxford
  • Josep Jansa, Acting Head of Section Emergency Preparedness & Response Support/Group Leader Response & Emergency Operations, 欧州疾病予防管理センター/European Centre for Disease Prevention & Control 

  • Jeffrey Almond, Former Vice President Discovery Research & Development, サノフィ/Sanofi & Visiting Professor, University of Oxford – Oxford Vaccine Group
  • Annaliesa Anderson, Chief Scientific Officer, Bacterial Vaccines & The Hospital Business Unit, ファイザー/Pfizer
  • Philip Beer, Physician Scientist & Precision Oncology Specialist, Sanger Institute
  • Prakash Bhuyan, MD, Vice President, Head of Infectious Diseases, Clinical Development, アストラゼネカ/Astrazeneca
  • Berend-Jan Bosch, Associate Professor, ユトレヒト大学/Utrecht University
  • Thomas Breuer, Senior Vice President, Chief Medical Officer, グラクソ・スミスクライン/GSK Vaccines
  • Ed Buurman, Director Alliances, CARB-X
  • Alessandro Carabelli, Research Lead, COVID-19 Genomics UK (COG-UK) consortium
  • Dr Miles Carroll, Head of Research & Development Institute, Public Health England
  • Jakob Cramer, Head of Clinical Development, CEPI
  • Isabel De La Mata, Principal Advisor for Health & Crisis Management, 欧州委員会/European Commission
  • Antu Dey, Senior Director, Research & Development, International AIDS Vaccine Initiative
  • Matthew Duchars, Chief Executive Officer, Vaccines Manufacturing & Innovation Centre
  • Dr Cynthia Dukes, VP, Drug Dev Consulting, ICON Clinical Research
  • Elisabeth Erlacher Vindel, Head of the Antimicrobial Resistance & Veterinary Products Department, World Organisation for Animal Health
  • Jose Angel M. Escribano, Chairman of the Board and Chief Scientific Officer, Algenex
  • Thomas Evans, CSO & Board Director, Vaccitech
  • Fred Fellouse, Senior Research Associate, University of Toronto, The Donnelly Centre
  • Anthony Fiore, Chief, Epidemiology Research & Innovations Branch, Division of Healthcare Quality Promotion, NCEZID, アメリカ疾病予防管理センター/CDC
  • Isabel Frost, Consultant, Vaccines and AMR, 世界保健機関/World Health Organization
  • Luc Gagnon, Vice President, Vaccine Sciences, Nexelis
  • Greg Glenn, President, Novavax
  • John Hammond, Group Leader, Genetics, Genomics, Immunology, パーブライト研究所/The Pirbright Institute
  • David Hering, Regional President, North America, ファイザー/Pfizer
  • Adrian Hill, Director & Professor, ジェンナー研究所/The Jenner Institute – University of Oxford
  • David Hipkiss, Chief Executive Officer, Enesi Pharma Limited
  • Jason Huang, CEO/CMO, Ascendo Biotech
  • Randall Hyer, Head of Medical Affairs, モデルナ/Moderna Therapeutics
  • Juanjo Infante, CEO, Vaxdyn
  • Josep Jansa, Acting Head of Section Emergency Preparedness & Response Support/Group Leader Response & Emergency Operations, 欧州疾病予防管理センター/European Centre for Disease Prevention & Control
  • Andreas Kuhn, Senior Vice President & Head of RNA Biochemistry & Manufacturing, BioNTech Ag
  • Calman Maclennan, Professor of Vaccine Immunology, ジェンナー研究所/Jenner Institute
  • Dr John Markels, President, メルク/Merck Vaccines
  • Jean-Cedric Meeus, Chief of Transport, ユニセフ/UNICEF
  • Kees Melief, Chief Scientific Officer, I.S.A. Pharmaceuticals Bv
  • Lisa Menning, Technical Officer, Vaccines & Biologicals, 世界保健機関/World Health Organisation
  • Lyn Morgan Marsden, Senior Director Public Affairs, サノフィパスツール/Sanofi Pasteur
  • Vish Nene, Co-leader Animal & Human Health program, International Livestock Research Institute
  • Dr Jan Poolman, Head Bacterial Vaccine Discovery & Early Development, ヤンセンファーマ/Janssen
  • David Robinson, Deputy Director, CMC Vaccines Development & Surveillance, ビル&メリンダ・ゲイツ財団/The Bill & Melinda Gates Foundation
  • Matthew Snape, Professor, Oxford Vaccine Group
  • Erin Spiegel, VP Clinical & Regulatory Affairs, PharmaJet
  • Stig Tollefsen, Technology Office Lead, CEPI
  • Jonathan Van-Tam, Deputy Chief Medical Officer, UK Department of Health

◆主要コンテンツテーマ:(最新版はこちらへ ⇒ アジェンダ

◆ショーケース:(出展/協賛企業・関連製品/サービス ⇒ プロダクト

◆参加者プロファイル:(参加者プロファイルページへ ⇒ 参加者)
※セッション内容等は頻繁に変更されます。日本語の情報が必要な場合はご相談ください。


視察、出張、出展、イベントのお悩み何でもご相談ください!


Venue

Palau de Congressos de Catalunya
94M5+6R バルセロナ, スペイン
Barcelona, Spain
+ Google Map
View Venue Website